Free and open · new CVEs checked every 20 minutesStatusRSSOpen dataContact

CVE-2026-15599: Unverified ownership vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute pardus-domain-jo

12
Routine
LOW 3.3

CVE-2026-15599 is a low-severity flaw (CVSS 3.3) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.

Unverified ownership vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute pardus-domain-joiner allows Privilege Abuse. This issue affects pardus-domain-joiner: before 0.5.5.

Why this priority

  • No elevated risk signals yet

No fix is published yet: follow the downgrade or mitigation steps.

Risk facts

CVSS score3.3 (Low)
Attack vectorLocal
Attack complexityLow
Privileges neededLow
User interactionNone
EPSS exploit chance0.1% (top 98%)
CISA exploited listNo
WeaknessCWE-283
Published2026-08-06
Last modified2026-10-23
Publisher (CNA): Computer Emergency Response Team of the Republic of Turkey

Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score

Timeline

Verify at the official source NVD · CVE Program · Report a problem with this page
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.

Quick answers

How do I fix CVE-2026-15599?

No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.

Is CVE-2026-15599 being exploited?

CVE-2026-15599 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

What does CVE-2026-15599 affect?

CVE-2026-15599 affects affected software. Severity is low (CVSS 3.3). Unverified ownership vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute pardus-domain-joiner allows Privilege Abuse. This issue affects pardus-domain-joiner: before 0.5.5.

How urgent is CVE-2026-15599?

Priority 12/100. No elevated risk signals yet.

References

← Back to latest CVEs